These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26003197)

  • 1. [Pulmonary manifestations of Langerhans cell histiocytosis].
    Obert J; Tazi A
    Rev Mal Respir; 2015 Oct; 32(8):850-66. PubMed ID: 26003197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How I manage pulmonary Langerhans cell histiocytosis.
    Lorillon G; Tazi A
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
    Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
    Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patchy colitis and interstitial lung disease.
    Coronel E; Micic D; Rubin DT
    Gastroenterology; 2015 Jan; 148(1):26-7. PubMed ID: 25450070
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists' Perspective.
    Roden AC; Yi ES
    Arch Pathol Lab Med; 2016 Mar; 140(3):230-40. PubMed ID: 26927717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Langerhans Cell Histiocytosis-associated Pulmonary Hypertension Showing a Drastic Improvement Following Smoking Cessation.
    Kinoshita Y; Watanabe K; Sakamoto A; Hidaka K
    Intern Med; 2016; 55(5):491-5. PubMed ID: 26935369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare interstitial lung disease: Pulmonary Langerhans Cell Histiocytosis in a young non smoking Indian female.
    Fernandes L; Vadala R; Mesquita AM; Vaideeswar P
    Indian J Tuberc; 2015 Jan; 62(1):46-9. PubMed ID: 25857566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Pulmonary Langerhans Cell Histiocytosis with BRAF V600E-negative and MAP2K1-posivtive Mutations Presenting as Diffuse Nodules in Chest High-resolution Computed Tomography After Smoking Cessation.
    Li Y; Cai HR; Ma M; Wang LJ; Yang J; Ding JJ; Miao LY
    Chin Med J (Engl); 2016 Jun; 129(11):1384-6. PubMed ID: 27231182
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary Langerhans Cell Histiocytosis.
    Shaw B; Borchers M; Zander D; Gupta N
    Semin Respir Crit Care Med; 2020 Apr; 41(2):269-279. PubMed ID: 32279297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis.
    Goyal G; Abeykoon JP; Hu M; Young JR; Shah MV; Bennani NN; Call TG; Hook CC; Pardanani A; Inwards DJ; Vassallo R; Ryu JH; Tobin WO; Koster MJ; Davidge-Pitts CJ; Ravindran A; Rech KL; Go RS;
    Am J Hematol; 2021 May; 96(5):E146-E150. PubMed ID: 33539584
    [No Abstract]   [Full Text] [Related]  

  • 11. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
    Héritier S; Emile JF; Barkaoui MA; Thomas C; Fraitag S; Boudjemaa S; Renaud F; Moreau A; Peuchmaur M; Chassagne-Clément C; Dijoud F; Rigau V; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Miron J; Jeziorski E; Plat G; Aladjidi N; Ferster A; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Armari-Alla C; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Lescoeur B; Gandemer V; Bodemer C; Lacave R; Hélias-Rodzewicz Z; Taly V; Geissmann F; Donadieu J
    J Clin Oncol; 2016 Sep; 34(25):3023-30. PubMed ID: 27382093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A rare interstitital lung disease in two smokers].
    Mayer D; Gadient G; Kuhn M
    Praxis (Bern 1994); 2010 May; 99(11):671-4. PubMed ID: 20506093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of treatment with a combination of cardiac rehabilitation and bosentan in patients with pulmonary Langerhans cell histiocytosis associated with pulmonary hypertension.
    Fukuda Y; Miura S; Fujimi K; Yano M; Nishikawa H; Yanagisawa J; Hiratsuka M; Shiraishi T; Iwasaki A; Saku K
    Eur J Prev Cardiol; 2014 Dec; 21(12):1481-3. PubMed ID: 23897898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking-related interstitial pneumonias and pulmonary Langerhans cell histiocytosis.
    Caminati A; Harari S
    Proc Am Thorac Soc; 2006 Jun; 3(4):299-306. PubMed ID: 16738193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary Langerhans cell histiocytosis].
    Popper HH
    Pathologe; 2015 Sep; 36(5):451-7. PubMed ID: 26289803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adult pulmonary Langerhans cell histiocytosis].
    Lorillon G; Meignin V; Tazi A
    Presse Med; 2017 Jan; 46(1):70-78. PubMed ID: 27816342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans Cell Histiocytosis and Other Histiocytic Diseases of the Lung.
    DeMartino E; Go RS; Vassallo R
    Clin Chest Med; 2016 Sep; 37(3):421-30. PubMed ID: 27514589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult pulmonary Langerhans' cell histiocytosis.
    Tazi A
    Eur Respir J; 2006 Jun; 27(6):1272-85. PubMed ID: 16772390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current understanding and management of pulmonary Langerhans cell histiocytosis.
    Vassallo R; Harari S; Tazi A
    Thorax; 2017 Oct; 72(10):937-945. PubMed ID: 28689173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards molecular-based management of childhood Langerhans cell histiocytosis.
    Héritier S; Emile JF; Hélias-Rodzewicz Z; Donadieu J
    Arch Pediatr; 2019 Jul; 26(5):301-307. PubMed ID: 31281037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.